Spots Global Cancer Trial Database for darolutamide (nubeqa, bay1841788)
Every month we try and update this database with for darolutamide (nubeqa, bay1841788) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely | NCT05202301 | Prostate Cancer | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer | |
| Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) | NCT04157088 | Prostatic Cance... | Darolutamide (N... Enzalutamide | 18 Years - | Bayer | |
| An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea | NCT06334120 | Non-metastatic ... Metastatic Horm... | Darolutamide (N... | 19 Years - | Bayer | |
| An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings | NCT05362149 | Non-metastatic ... | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer | |
| Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer | NCT04464226 | Cancer | Darolutamide (N... | 18 Years - | Bayer | |
| An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States | NCT06204302 | Non-metastatic ... Non-metastatic ... | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer | |
| A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) | NCT05348876 | Non-metastatic ... | Darolutamide (N... | 18 Years - | Bayer | |
| Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer | NCT04736199 | Prostatic Neopl... | Darolutamide (N... Placebo Androgen depriv... | 18 Years - | Bayer | |
| A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely | NCT05202301 | Prostate Cancer | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer | |
| A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely | NCT05202301 | Prostate Cancer | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer | |
| An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings | NCT05362149 | Non-metastatic ... | Darolutamide (N... Enzalutamide Apalutamide | 18 Years - | Bayer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
